INS and metabolic dysfunction-associated steatotic liver disease: In patients with NAFLD, it has been reported that increased BCAA levels are likely linked to increased insulin resistance [59,60], and worsening insulin resistance in the setting of NAFLD is associated with the progressive inability of insulin to suppress plasma BCAAs, which in turn results in their elevated plasma levels [61,62].